US Broker Ratings

Illumina, Inc. (ILMN) Stock Analysis: Evaluating Its Market Position Amidst Mixed Analyst Ratings

Illumina, Inc. (NASDAQ: ILMN), a key player in the healthcare sector specializing in diagnostics and research, commands a significant presence in the genetic and genomic analysis market. Headquartered in San..

Exelixis, Inc. (EXEL) Stock Analysis: Navigating the Biotech Sector with Solid Revenue Growth and Analyst Confidence

Exelixis, Inc. (NASDAQ: EXEL) stands as a significant player in the biotechnology industry, primarily focusing on developing treatments for challenging cancer types. With a market capitalization of $12.45 billion, Exelixis..

RadNet, Inc. (RDNT) Stock Analysis: A 25% Upside Potential Amidst Robust Revenue Growth

RadNet, Inc. (NASDAQ: RDNT) is capturing investor attention with its impressive 25.38% potential upside, as indicated by analyst target prices. This healthcare sector stalwart, specializing in diagnostics and research, offers..

Edwards Lifesciences Corporation (EW) Stock Analysis: Exploring a 10% Upside Amid Robust Revenue Growth

Edwards Lifesciences Corporation (NYSE: EW) is making waves in the healthcare sector, particularly within the medical devices industry. With a significant market cap of $50.99 billion, the company stands as..

Vertex Pharmaceuticals (VRTX) Stock Analysis: Evaluating the 6.27% Upside in Biotech Innovation

Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) stands as a prominent player in the biotechnology sector, primarily focusing on therapies for cystic fibrosis and other severe diseases. As of the latest data,..

Charles River Laboratories (CRL): Investor Outlook Reveals Mixed Momentum Amidst Steady Analyst Confidence

Charles River Laboratories International, Inc. (NYSE: CRL) stands at a fascinating juncture for investors, blending a strong market presence with challenging financial metrics. Headquartered in Wilmington, Massachusetts, the company has..

Hologic, Inc. (HOLX) Stock Analysis: A Healthcare Powerhouse with Solid Growth Prospects

Hologic, Inc. (NASDAQ: HOLX) stands as a formidable entity within the healthcare sector, specifically in the medical instruments and supplies industry. With a market capitalization of $16.62 billion, this Massachusetts-based..

McKesson Corporation (MCK) Stock Analysis: Potential 13.41% Upside with Robust Revenue Growth

McKesson Corporation (NYSE: MCK), a stalwart in the healthcare sector, continues to capture investor attention with its compelling market dynamics and promising growth outlook. As a leader in medical distribution,..

BioNTech SE (BNTX) Stock Analysis: A 47% Upside Potential Amidst Promising Clinical Trials

BioNTech SE (NASDAQ: BNTX), headquartered in Mainz, Germany, has made waves in the biotechnology sector with its innovative approach to developing immunotherapies for cancer and infectious diseases. With a market..

Legend Biotech Corporation (LEGN): Analyst Consensus Highlights a Remarkable 220% Potential Upside

Legend Biotech Corporation (NASDAQ: LEGN) is carving a niche in the biotech sector with its innovative approach to oncology treatments. With a market capitalization of $4.16 billion, this Somerset, New..

Universal Health Services, Inc. (UHS) Stock Analysis: Exploring the 10.78% Upside Potential

Universal Health Services, Inc. (NYSE: UHS) is a prominent player in the healthcare sector, specializing in the operation of acute care hospitals and behavioral health care facilities. Headquartered in King..

Pfizer, Inc. (PFE) Investor Outlook: Evaluating a 14% Potential Upside and a Robust Dividend Yield

Pfizer, Inc. (NYSE: PFE) stands as a titan in the healthcare sector, best known for its significant contributions to drug manufacturing on a global scale. The company’s profile is marked..

Masimo Corporation (MASI) Stock Analysis: Exploring a 38% Potential Upside Amid Healthcare Innovations

Masimo Corporation (NASDAQ: MASI), a prominent player in the healthcare sector, is capturing investor interest with a potential upside of 38.41%. Despite recent market challenges, Masimo’s innovative strides in medical..

Globus Medical, Inc. (GMED) Stock Analysis: A Promising 11.67% Upside in the Booming Medical Devices Sector

Globus Medical, Inc. (NYSE: GMED), a prominent player in the healthcare sector, is making waves within the medical devices industry. With a robust market capitalization of $11.94 billion, this U.S.-based..

Repligen Corporation (RGEN) Stock Analysis: Exploring the 13.85% Potential Upside

Repligen Corporation (NASDAQ: RGEN), a prominent player in the healthcare sector, particularly in the medical instruments and supplies industry, continues to capture the attention of investors. With a market capitalization..

Revolution Medicines, Inc. (RVMD) Stock Analysis: Exploring the Biotech’s Precision Oncology Potential

Revolution Medicines, Inc. (RVMD) is making waves in the biotechnology sector with its pioneering approach to treating RAS-addicted cancers. As a clinical-stage precision oncology company, Revolution Medicines is focused on..

Inspire Medical Systems, Inc. (INSP) Stock Analysis: Unlocking a 46.77% Upside Potential in the Medical Device Sector

Inspire Medical Systems, Inc. (NASDAQ: INSP) stands out in the healthcare sector, particularly within the medical device industry, as a promising investment opportunity. With a market capitalization of $2.82 billion,..

Regencell Bioscience Holdings (RGC) Stock Analysis: Evaluating the $10.46 Billion TCM Innovator

Regencell Bioscience Holdings Limited (NASDAQ: RGC) is carving out a niche in the healthcare sector with its focus on Traditional Chinese Medicine (TCM) aimed at treating neurocognitive disorders. Operating out..

HCA Healthcare, Inc. (HCA): Investor Outlook with Strong Revenue Growth and Analyst Consensus

HCA Healthcare, Inc. (NYSE: HCA) is a prominent name in the healthcare sector, operating an extensive network of medical care facilities across the United States. With a robust market capitalization..

Amgen Inc. (AMGN) Investor Outlook: Strong Revenue Growth and Robust Dividend Yield Highlight Investment Appeal

Amgen Inc. (NASDAQ: AMGN), a titan in the healthcare sector, continues to capture investor attention with its impressive revenue growth and robust dividend yield. As a leading player in the..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds